Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 1
1974 1
1975 3
1977 1
1978 3
1979 5
1980 3
1981 2
1982 7
1983 3
1984 4
1985 1
1986 2
1988 2
1989 6
1990 1
1991 9
1992 20
1993 5
1994 4
1995 9
1996 3
1997 7
1998 5
1999 6
2000 4
2001 8
2002 5
2003 11
2004 15
2005 12
2006 12
2007 5
2008 12
2009 7
2010 17
2011 11
2012 17
2013 23
2014 28
2015 26
2016 23
2017 21
2018 27
2019 19
2020 30
2021 26
2022 28
2023 19
2024 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

474 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
Mucormycosis.
Hernández JL, Buckley CJ. Hernández JL, et al. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 31335084 Free Books & Documents.
Biologic therapy in ANCA-negative vasculitis.
Loricera J, Blanco R, Hernández JL, Pina T, González-Vela MC, González-Gay MA. Loricera J, et al. Among authors: hernandez jl. Int Immunopharmacol. 2015 Aug;27(2):213-9. doi: 10.1016/j.intimp.2015.03.020. Epub 2015 Mar 28. Int Immunopharmacol. 2015. PMID: 25828585 Review.
Medication adherence in schizophrenia.
Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Acosta FJ, et al. Among authors: hernandez jl. World J Psychiatry. 2012 Oct 22;2(5):74-82. doi: 10.5498/wjp.v2.i5.74. World J Psychiatry. 2012. PMID: 24175171 Free PMC article. Review.
Profiling and inhibiting reversible palmitoylation.
Hernandez JL, Majmudar JD, Martin BR. Hernandez JL, et al. Curr Opin Chem Biol. 2013 Feb;17(1):20-6. doi: 10.1016/j.cbpa.2012.11.023. Epub 2013 Jan 1. Curr Opin Chem Biol. 2013. PMID: 23287289 Free PMC article. Review.
Are the new 2023 ACR/EULAR classification criteria suitable for advancing the knowledge of obstetric antiphospholipid syndrome?
Martínez-Taboada VM, Gómez AM, Merino A, López-Hoyos M, Del Barrio-Longarela S, Comins-Boo A, Galvez R, Hernández JL. Martínez-Taboada VM, et al. Among authors: hernandez jl. Autoimmun Rev. 2024 Jul-Aug;23(7-8):103592. doi: 10.1016/j.autrev.2024.103592. Epub 2024 Aug 9. Autoimmun Rev. 2024. PMID: 39127177 No abstract available.
Pharmacogenomics of osteoporosis: a pathway approach.
Riancho JA, Hernández JL. Riancho JA, et al. Among authors: hernandez jl. Pharmacogenomics. 2012 May;13(7):815-29. doi: 10.2217/pgs.12.50. Pharmacogenomics. 2012. PMID: 22594513 Review.
Ovarian remnant syndrome.
Magtibay PM, Nyholm JL, Hernandez JL, Podratz KC. Magtibay PM, et al. Among authors: hernandez jl. Am J Obstet Gynecol. 2005 Dec;193(6):2062-6. doi: 10.1016/j.ajog.2005.07.067. Am J Obstet Gynecol. 2005. PMID: 16325616
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Calderón-Goercke M, Loricera J, Moriano C, Castañeda S, Narváez J, Aldasoro V, Maiz O, Melero R, Villa JI, Vela P, Romero-Yuste S, Callejas JL, de Miguel E, Galíndez-Agirregoikoa E, Sivera F, Fernández-López JC, Galisteo C, Ferraz-Amaro I, Sanchéz-Martín J, Sánchez-Bilbao L, González-Gay MA, Hernández JL, Blanco R; Tocilizumab in Giant Cell Arteritis Spanish Collaborative Group. Calderón-Goercke M, et al. Among authors: hernandez jl. Clin Exp Rheumatol. 2023 Apr;41(4):829-836. doi: 10.55563/clinexprheumatol/oqs8u9. Epub 2022 Nov 2. Clin Exp Rheumatol. 2023. PMID: 36377586 Free article.
474 results